104 related articles for article (PubMed ID: 38870007)
1. Long-term outcomes of active vaccination against de novo hepatitis B among pediatric recipients of living donor liver transplantations with anti-HBc (+) grafts: a retrospective case-control study.
Yong CC; Lin YH; Espinosa WZ; Chen IH; Wang SH; Chan YC; Chen CL; Lin CC
Int J Surg; 2024 Jun; ():. PubMed ID: 38870007
[TBL] [Abstract][Full Text] [Related]
2. Active immunization for prevention of De novo hepatitis B virus infection after adult living donor liver transplantation with a hepatitis B core antigen-positive graft.
Wang SH; Loh PY; Lin TL; Lin LM; Li WF; Lin YH; Lin CC; Chen CL
Liver Transpl; 2017 Oct; 23(10):1266-1272. PubMed ID: 28691231
[TBL] [Abstract][Full Text] [Related]
3. Active immunization to prevent de novo hepatitis B virus infection in pediatric live donor liver recipients.
Lin CC; Chen CL; Concejero A; Wang CC; Wang SH; Liu YW; Yang CH; Yong CC; Lin TS; Jawan B; Cheng YF; Eng HL
Am J Transplant; 2007 Jan; 7(1):195-200. PubMed ID: 17227568
[TBL] [Abstract][Full Text] [Related]
4. The use of hepatitis B immunoglobulin with or without hepatitis B vaccine to prevent de novo hepatitis B in pediatric recipients of anti-HBc-positive livers.
Yamashiki N; Yoshizawa A; Ueda Y; Kaido T; Okajima H; Marusawa H; Seno H; Uemoto S
Pediatr Transplant; 2018 Aug; 22(5):e13227. PubMed ID: 29761899
[TBL] [Abstract][Full Text] [Related]
5. Liver transplantation using hepatitis B core positive grafts with antiviral monotherapy prophylaxis.
Wong TC; Fung JY; Cui TY; Lam AH; Dai JW; Chan AC; Cheung TT; Chok KS; Ng KK; Lo CM
J Hepatol; 2019 Jun; 70(6):1114-1122. PubMed ID: 30871981
[TBL] [Abstract][Full Text] [Related]
6. De novo hepatitis b prophylaxis with hepatitis B virus vaccine and hepatitis B immunoglobulin in pediatric recipients of core antibody-positive livers.
Lee S; Kim JM; Choi GS; Park JB; Kwon CH; Choe YH; Joh JW; Lee SK
Liver Transpl; 2016 Feb; 22(2):247-51. PubMed ID: 26600319
[TBL] [Abstract][Full Text] [Related]
7. Prevention of de novo hepatitis B virus infection in living donor liver transplantation using hepatitis B core antibody positive donors.
Chen YS; Wang CC; de Villa VH; Wang SH; Cheng YF; Huang TL; Jawan B; Chiu KW; Chen CL
Clin Transplant; 2002 Dec; 16(6):405-9. PubMed ID: 12437618
[TBL] [Abstract][Full Text] [Related]
8. Inferior graft survival of hepatitis B core positive grafts is not influenced by post-transplant hepatitis B infection in liver recipients--5-year single-center experience.
Brandl A; Stolzlechner P; Eschertzhuber S; Aigner F; Weiss S; Vogel W; Krannich A; Neururer S; Pratschke J; Graziadei I; Öllinger R
Transpl Int; 2016 Apr; 29(4):471-82. PubMed ID: 26716608
[TBL] [Abstract][Full Text] [Related]
9. Long-term protection against hepatitis B in pediatric liver recipients can be achieved effectively with vaccination after transplantation.
Kwon CH; Suh KS; Yi NJ; Chang SH; Cho YB; Cho JY; Lee HJ; Seo JK; Lee KU
Pediatr Transplant; 2006 Jun; 10(4):479-86. PubMed ID: 16712607
[TBL] [Abstract][Full Text] [Related]
10. Active immunization against de novo hepatitis B virus infection in pediatric patients after liver transplantation.
Chang SH; Suh KS; Yi NJ; Choi SH; Lee HJ; Seo JK; Lee KU
Hepatology; 2003 Jun; 37(6):1329-34. PubMed ID: 12774011
[TBL] [Abstract][Full Text] [Related]
11. De novo hepatitis B virus infection from anti-HBc-positive donors in pediatric living donor liver transplantation.
Xi ZF; Xia Q; Zhang JJ; Chen XS; Han LZ; Zhu JJ; Wang SY; Qiu DK
J Dig Dis; 2013 Aug; 14(8):439-45. PubMed ID: 23638710
[TBL] [Abstract][Full Text] [Related]
12. Long-term efficacy of hepatitis B vaccination as post-transplant prophylaxis in hepatitis B surface antigen (HBsAg) positive recipients and HBsAg negative recipients of anti-hepatitis B core positive grafts.
Yoshizawa A; Yamashiki N; Ueda Y; Kaido T; Okajima H; Marusawa H; Chiba T; Uemoto S
Hepatol Res; 2016 May; 46(6):541-51. PubMed ID: 26348993
[TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness and long-term outcomes of liver transplantation using hepatitis B core antibody-positive grafts with hepatitis B immunoglobulin prophylaxis in Korea.
Kim KD; Lee JE; Kim JM; Lee O; Hwang NY; Rhu J; Choi GS; Kim K; Joh JW
Clin Mol Hepatol; 2021 Oct; 27(4):603-615. PubMed ID: 34492755
[TBL] [Abstract][Full Text] [Related]
14. HBV-infection rate and long-term outcome after liver-transplantation of anti-HBc-positive liver-grafts to HBV-naïve recipients: A retrospective study.
Hornuss D; Rudi A; Koerner L; Mohr I; Merle U; Wehling C; Rupp C; Dill MT; Golriz M; Schnitzler P; Brenner T; Mehrabi A; Weiss KH; Mieth M
Clin Res Hepatol Gastroenterol; 2021 Mar; 45(2):101496. PubMed ID: 33740476
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis B Reactivation in Liver Transplant Recipients With Hepatitis B Virus Core Antibody Positive Grafts: a Retrospective Study.
Khiangte B; Kothakota SR; Sasidharan M; Kareem H; Nair AK; Kumar VV; Kanala JR; Kumar PC
J Clin Exp Hepatol; 2020; 10(6):548-554. PubMed ID: 33311891
[TBL] [Abstract][Full Text] [Related]
16. Liver grafts from anti-hepatitis B core positive donors: a systematic review.
Cholongitas E; Papatheodoridis GV; Burroughs AK
J Hepatol; 2010 Feb; 52(2):272-9. PubMed ID: 20034693
[TBL] [Abstract][Full Text] [Related]
17. Prevention of de novo hepatitis B infection in recipients of hepatic allografts from anti-HBc positive donors.
Dodson SF; Bonham CA; Geller DA; Cacciarelli TV; Rakela J; Fung JJ
Transplantation; 1999 Oct; 68(7):1058-61. PubMed ID: 10532552
[TBL] [Abstract][Full Text] [Related]
18. Safety of hepatitis B virus core antibody-positive grafts in liver transplantation: A single-center experience in China.
Lei M; Yan LN; Yang JY; Wen TF; Li B; Wang WT; Wu H; Xu MQ; Chen ZY; Wei YG
World J Gastroenterol; 2018 Dec; 24(48):5525-5536. PubMed ID: 30622380
[TBL] [Abstract][Full Text] [Related]
19. High-titer antibody to hepatitis B surface antigen before liver transplantation can prevent de novo hepatitis B infection.
Su WJ; Ho MC; Ni YH; Chen HL; Hu RH; Wu YM; Chang MH; Lee PH
J Pediatr Gastroenterol Nutr; 2009 Feb; 48(2):203-8. PubMed ID: 19179883
[TBL] [Abstract][Full Text] [Related]
20. De novo hepatitis B infection following liver transplantation with core antibody positive grafts: The role of surface antibody status in guiding long-term prophylaxis.
Busebee B; Myhre L; Mara K; Aqel B; Taner T; Watt KD
Clin Transplant; 2024 Feb; 38(2):e15263. PubMed ID: 38375953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
